View Our Latest Perspectives
Innovative ideas and insightsRead More
David Hetz joined Cain Brothers in 2011 as Vice Chairman and has been involved in healthcare finance for 31 years as an investment banker, private equity and venture capital investor, and corporate board member. Mr. Hetz’s notable transactions include the investment in Alere and its subsequent sale to TA Associates; the strategic repositioning of Nellcor and its acquisitions of Puritan-Bennett, Aequitron, and Infrasonics; the merger of Homedco and Abbey Healthcare to create Apria; Johnson & Johnson’s acquisitions of Biopsys, Gynecare, and Indigo Medical; Chiron’s strategic partnership with Novartis; and Bioscrip’s $62 million PIPE financing. He is a member of the Firm’s Executive Committee and Board of Directors and leads the Firm’s principal investing activities as Managing General Partner of the CB Equity Co-Investment Fund.
Prior to joining Cain Brothers, in 2001 Mr. Hetz was the co-founding partner of Cutlass Capital, LLC, a venture capital firm investing in healthcare services and medical technology companies. Previously, he was with Robertson, Stephens & Co. for 13 years, serving as co-head of global investment banking, head of the mergers & acquisitions department, and member of the management committee. Over the years he has served on numerous public and private healthcare company boards.
Mr. Hetz earned a BA in Economics from Claremont McKenna College and an MBA from Harvard Business School. Mr. Hetz serves as a trustee of Claremont McKenna College and the Middlesex School and as an advisory board member of the Kravis Leadership Institute.